Novo Nordisk AS (XTER:NOV)
€ 99.51 -3.09 (-3.01%) Market Cap: 442.81 Bil Enterprise Value: 440.41 Bil PE Ratio: 35.07 PB Ratio: 27.45 GF Score: 91/100

Novo Nordisk A/S Annual Shareholders Meeting Transcript

Mar 23, 2023 / 01:00PM GMT
Release Date Price: €69.3 (+1.38%)
Helge Lund;S;Independent Chairman of the Board
Novo Nordisk A

/-

Good afternoon. On behalf of the Board, a warm welcome to Novo Nordisk Annual General Meeting in 2023. My name is Helge Lund, and I'm the Chair of the Board of Directors. This year, I'm especially delighted to open the Annual General Meeting as 2023 marks a major milestone in the evolution of Novo Nordisk, founded in 1923, this year, the nodes, Novo Nordisk Centenary and underlines the longevity and value of Novo Nordisk distinct purpose. We'll come back to that a little later.

For those of you who prefer Danish or English simultaneous translation is available, here in the Bella Center and online participants can choose the preferred language in the broadcast system. In 2023, Novo Nordisk turns 100 years. For a century, our company has been consistent in the overall mission to drive change to defeat diabetes and other serious chronic diseases.

However, given the health challenges that pose a threat to people's lives and livelihoods, Among these, the rights of obesity as one of the world's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot